SMi proudly present their 2nd Annual conference on Peptides taking place on 8th & 9th July 2015 in London. The conference sets the stage for attendees to gain valuable insight into innovative topics such as Cyclic Peptides: R&D platforms, manufacture and stability, Oral Delivery of peptides, Cell permeable peptide therapeutics for cancer treatments and Development of Peptides for the Clinic. Along with this, the program will provide insight into Formulating Solutions for Delivery and round table discussions on case studies demonstrating the translation of R&D peptides to the clinic.

This years event will allow delegates to get a unique insight into the field and the developments that have been made. Keynote talks from Lutz  Jermutus Senior Director of  R&D at Medimmune, Dan Teufel  CSO at Bicycle Therapeutics and Jorg Vollmer CEO at Nexigen will allow for a greater understanding of breakthrough peptide therapeutics and the platforms behind them.

The peptides market is currently worth $14.1Bn and is growing at an average CAGR of 8.7%. The market is forcasted to grow to $25.5Bn at the end of 2018. The market will grow due to the explosion of non communicable diseases such as metabolic and cardiovascular diseases that that have become endemic in our society.

Peptide technology has been growing at an impressive rate with enhancements in synthesis mechanisms such as solid and liquid phase synthesis. By attending this event you will gain a greater understanding of the techniques used and what systems to implement.

There has also been an impressive growth in the cancer peptide market with a CAGR of  9.4%. Ground breaking "first in class drugs" will be presented to the delegation with key presentations being made on novel VEGF inhibitor drugs and mechanisms of delivering drugs intercellularly.

Orally available drugs are also a key constituent of the meeting with multiple talks providing an explanation to where we currently are in the field and what breakthrough technologies have been developed. A key  talk will be provided by Roger New of  Proxima concepts on a new orally available insulin delivery platform.

Currently the peptide market makes up only 1.55% of the overall market, but this is expected to change thanks to new technologies and the increased number of peptides in the pipeline with 120 in the clinical trial phase and 600 in the preclinical stage.


  • ENHANCE understandings of current peptide R&D platforms to allow for rapid and efficient discovery of new compounds.
  • GAIN a greater insight into oral delivery mechanisms to allow for greater access to the clinic and increased patient compliance.
  • LEARN how to translate R&D from the bench to the clinic to ensure smooth transitions.
  • EXPAND Familiarity about current peptide synthesis mechanisms and gain an insight into what technologies are available to synthesise peptides in an effective manner.
  • DEVELOP knowledge on the latest breakthrough peptide therapeutics and first in class drugs to treat non-communicable diseases.


  • Laboratory Head
  • Research Associate
  • CEO
  • CSO
  • Head of Late Discovery
  • Director of Peptide and Protein Chemistry
  • Head of Peptide Chemistry
  • Investigator III
  • Investigator II
  • Strategic Marketing Director
  • Manufacturing Director
  • Peptide Discovery Group, Exploratory Medicinal Chemistry Unit
  • Fellow
  • Associate Scientist
  • BDM
  • Associate Director
  • Director of Chemistry
  • Formulation Scientist
  • Principle RA
  • Marketing and Advertising Coordinator
  • Communication Manager
  • Technical Sales
  • Senior Scientist

ALK; ALK Abello; Bachem Feinchemikalien A G; Bicycle Therapeutics Limited; Camarus A B; Chemi Spa; Entirs Biopharma; Gent University; GSK; Haemostatix Ltd; IPSEN; Ipsen Inc.; Ironwood Pharmaceuticals Inc; Kings College London; Med Immune; MedImmune; Nexigen; Novaliq GmbH; Novartis Pharmaceuticals Corp; Novo Nordisk Pharmaceuticals Incorporated; Novozymes Biopharma; Pfizer; Phylogica Ltd; PolyPeptide Laboratories France SAS; Protagonist Therapeutics; Ra Pharmaceuticals ; Sanofi-Aventis; Syntaxin Ltd; Takeda Cambridge Ltd; Teva Pharmachemie;

Conference programme

8:30 Registration & Coffee

9:00 Chairman's Opening Remarks

Lutz Jermutus

Lutz Jermutus, Senior Director, R&D & Product Development Team Leader, MedImmune
View Bio

9:10 Past, present and future of Peptide Platforms: Challenges and Opportunities

Dan Teufel

Dan Teufel, Head of Chemsitry, Bicycle Therapeutics Limited

9:50 Peptide-nanoconjugates: applications in biomedicine

Rosario Sanchez-Martin

Rosario Sanchez-Martin, Group Leader of NANOCHEMBIO research team , GENYO
View Bio

• Peptide conjugation techniques, an introduction.
• Peptide drug conjugation to nanoparticles, a multifunctional approach
• Peptide based Intracellular nanosensors
• Peptide based selective delivery nanodevices

10:30 Morning Coffee

11:00 Libraries of DNA encoded peptidic macrocycles for drug discovery

Stephen Hale

Stephen Hale, Senior Vice President, Biological Sciences, Ensemble Therapeutics
View Bio

• Large libraries of synthetically-accessible peptidic macrocycles facilitate hit identification
• Interrogating encoded libraries is a rapid and massively parallel process
• Practical applications of Ensemble’s discovery platform

11:40 Peptide aggregation: Mechanism, challenges on cycle life development and analytical tools

Anna-Karin  Lundback

Anna-Karin Lundback, Scientist I, MedImmune

• Understanding aggregation pathways
• Tools to study physical degradation
• Selecting the best candidate for development

12:20 Networking Lunch

13:30 Peptide Nucleic Acids as encoding and diagnostic tools

Juan J  Diaz-Mochon

Juan J Diaz-Mochon, Ramon y Cajal Fellow , GENYO
View Bio

• PNA encoded peptide libraries - cell based assays Peptide drug conjugation to nanoparticles, a multifunctional approach
• Dynamic Chemistry for enzyme-free nucleic acid testing for diagnostic applications. SMART Nucleobases and modified PNAs.
• SNP Genotyping by Dynamic Chemistry and MALDI-Tof

14:10 ROUND TABLE DISCUSSION:Translating peptide R&D to the clinic

Lutz Jermutus

Lutz Jermutus, Senior Director, R&D & Product Development Team Leader, MedImmune
View Bio

·          An invaluable round table session allowing for business development

·          Session introducing case studies into how individuals upscale production

·          Challenges faced in transferring R&D from the bench to clinic and how these problems were solved


14:50 Afternoon Tea

15:20 Genetic selection of cyclic peptide inhibitors of protein-protein interactions

Ali  Tavassoli

Ali Tavassoli, Reader in Chemical Biology, University Of Southampton
View Bio

• Cyclic peptide libraries of around a hundred million members are readily prepared with SICLOPPS
• The activity of each peptide is measured against a given protein-protein interaction using a reverse two-hybrid system
• This plug and play platform has yielded several first in class inhibitors

16:00 Using structural biology in the design, production and study of cancer targeting peptides

Mark  Howard

Mark Howard, Reader in Biological NMR Spectroscopy, University Of Kent
View Bio

• Synthetic and recombinant peptides designed by structural analysis
• NMR spectroscopy used to confirm structure and receptor specificity
• Disulphide bond cyclisation can create changes in peptide specificity

16:40 Chairman’s Closing Remarks and Close of Day One

Lutz Jermutus

Lutz Jermutus, Senior Director, R&D & Product Development Team Leader, MedImmune
View Bio

8:30 Registration & Coffee

9:00 Chairman's Opening Remarks

Alexandra Matzke-Ogi

Alexandra Matzke-Ogi, CSO, Amcure

9:10 A novel class of peptide coagulant for surgical bleeding

Renata Zbozien

Renata Zbozien, Research Manager, Haemostatix Ltd
View Bio

• Designing against multiple criteria
• SAR optimisation
• Formulation

9:50 Delivery of peptides via the oral route

·          Overcoming the intestinal barrier

·          Oral insulin

·          Delivery to liver


Roger New

Roger New, Co-founder & CSO, Proxima Concepts Ltd
View Bio

10:30 Morning Coffee

11:00 Biological insights into therapeutic peptide modification: The development of stapled peptides to modulate BRCA2-RAD51 interaction

Chiara Valenzano

Chiara Valenzano, Principal Scientist, UCB Celltech
View Bio

  • Chemicals strategies to improve peptides biological activity  and  overcome the intrinsic limitations of peptides as chemical tool and therapeutic agents, will be described
  • Case study: investigation of BRCA2-RAD51 protein-protein interaction, as an example of stapled peptides that succeeded  where a small molecules approach  failed.
  • 11:40 Metallohelix peptidomimetics – a new area of chemical space

    Peter  Scott

    Peter Scott, Professor of Chemistry, University of Warwick
    View Bio

    • Up to now, helical metal (e.g. Fe) complexes have been insoluble, unstable, unfunctionalised, highly symmetrical and racemic.
    • We have addressed all these problems to create self-assembling architectures on a realistic scale that appear to behave like short amphipathic helices.
    • There is high structure dependent activity in cancer and antimicrobial screens, and apparently low toxicity.

    12:20 Networking Lunch

    13:30 Antimicrobial peptides and gene-delivery peptides

    James Mason

    James Mason , Senior Lecturer, Kings College London
    View Bio

    •          Gaining a new tool to improve therapeutic attributes of therapeutic proteins
    •          Recent advances in the field of antimicrobial peptides
    •          Structural functional relationships between modifications and therapeutics

    14:10 Development of a first-in-class drug candidate for the treatment of metastatic cancer

    Alexandra Matzke-Ogi

    Alexandra Matzke-Ogi, CSO, Amcure

    14:50 Afternoon Tea

    15:20 Drugging the Undruggables - Cell-permeable peptide inhibitors of cancer stem cell-relevant signalling pathways

    Joerg Vollmer

    Joerg Vollmer, CEO, Nexigen GmbH

    • Tumor recurrence and spread caused by cancer stem cells are one of the challenges in today’s treatment of cancer
    • Cell-permeable peptide therapeutics targeting protein-protein interactions are an attractive alternative to conventional therapies to inactivate intracellular cancer-relevant signaling pathways
    • Nexigen’s NexiTides target such pathways, have strong in vitro anti-cancer stemness activity and are effective in models of tumor growth and metastases

    16:00 Advances in oral peptide delivery

    David Brayden

    David Brayden, Professor of advanced drug delivery, University College Dublin
    View Bio

    • Selected analyses of technologies that have reached clinical
    • Addressing mechanisms of action of intestinal permeation enhancer-based systems
    • Toxicology issues of permeation enhancers:  perceived or real?

    16:40 Chairman’s Closing Remarks and Close of Day Two

    Alexandra Matzke-Ogi

    Alexandra Matzke-Ogi, CSO, Amcure


    Sponsors and Exhibitors

    Official Media Partner



    Cyclic Peptides: Discovery, Development and Deployment

    Cyclic Peptides: Discovery, Development and Deployment

    Marriott Regents Park
    7th July 2015
    London, United Kingdom

    Is your name on the list for Peptides 2015?


    Peptides Speaker Interview with University College Dublin


    Peptides Speaker Interview with Ensemble Therapeutics


    Sponsors and Exhibitors


    Sponsors and Exhibitors

    Bachem provides comprehensive services to the pharma and biotech industries. It specializes in the development of innovative, efficient manufacturing processes and the reliable production of peptide-based APIs. The group has a global reach with more experience and know-how than any other company in the industry. Bachem. Pioneering Partner for Peptides


    Sponsors and Exhibitors

    The PolyPeptide Group is a world leading peptide drug substance manufacturer with six manufacturing facilities distributed over 5 countries and 3 continents (Belgium, France, India, Sweden, USA). Our exclusive focus on peptides for pre-clinical, clinical and commercial use provides our customers with the highest quality products and services that exceed expectations.

    Media Partners

    The Protein Society

    Official Media Partner

    The Protein Society is an international, trans-disciplinary community of investigators dedicated to the study of protein structure, function, and design. A non-profit scientific and educational organization, the Society provides forums for scientific collaboration and communication with respect to all aspects of protein science.

    Media Partners

    Pharmaceutical Technology


    Pharmaceutical-technology.com is the only website focusing specifically on issues relevant to pharmaceutical professionals working with technology, be it development, engineering, IT or production. Pharmaceutical-technology.com brings you the latest in industry projects and updates, along with the news, views and trends that leading professionals – from senior executives to manufacturing managers and heads of procurement – require to stay on top of their field.



    GBI is an information, applications, and services company focused on the healthcare industry. Leveraging data from across the healthcare value chain, GBI creates web and mobile applications that enable individuals and organizations to make better decisions and communicate more effectively.

    Contract Biotechnology


    Contract-Biotechnology.com is a web-based platform for laboratory outsourcing solutions. It is an online R&D matching tool that connects Scientifics and service and product providers worldwide. The platform Contract-Biotechnology.com would help you in the process of finding the right partner saving time and money, because with one single and secure application you would be able to receive multiple quotes quickly, keeping your contact information confidential. Contract-Biotechnology.com is the new Collaboration Network Model for Discovery Research and Development. Contract-Biotechnology.com team has extensive experience working for pharmaceuticals, biotechs, universities and academic research institutes and can help you addressing your key gaps.



    PharmaVOICE magazine, and its supporting VIEW publications, provide commentary about the challenges and trends impacting the life-sciences industry, covering a range of issues from molecule through market. PharmaVOICE's more than 41,000 U.S.-based subscribers are also kept abreast of the latest trends through additional media resources, including WebSeminars, Podcasts, Videocasts, and White Papers.



    www.PharmCast.com is the world leading website designed specifically for pharmaceutical, clinical and biotechnology professionals. www.PharmCast.com brings up-to-date information on pharmaceutical patents, FDA, news, jobs and Buyer's Guide to our visitors. It was created and is maintained by pharmaceutical and biotechnology professionals. Visit www.PharmCast.com and discover for yourself why it is so popular among professionals.



    PMR (www.pmrcorporate.com) is a British-American company providing market information, advice and services to international businesses interested in Central and Eastern European countries as well as other emerging markets. PMR's key areas of operation include business publications (through PMR Publications), consultancy (through PMR Consulting) and market research (through PMR Research ). Being present on the market since 1995, offering high international standards in projects and publications, as well as providing one of the most frequently visited and top-ranked websites, PMR is one of the largest companies of its type in the region.



    pharmaphorum drives innovation within the pharmaceutical industry, by bringing healthcare together through a suite of media services that help produce and disseminate thought leadership, combined with an online platform for communicating messages to a global audience.Visit www.pharmaphorum.com



    http://www.fiercebiotech.com" target="_blank"> sponsor image


    http://www.fiercebiotech.com" target="_blank" class="link" align="right"> http://www.fiercebiotech.com

    FierceBiotech is the biotech industry's daily monitor. Biotech executives rely on FierceBiotech to stay up to speed on biotech corporations, FDA approvals & regulations, industry mergers & acquisitions, clinical trials, and more. Beyond the news of the day, our editors produce in-depth features on industry leaders and up-and-comers, the regulatory environment, and market trends. In addition to our comprehensive website and free email newsletter, you have the opportunity to attend our webinars, peruse our whitepaper library and benefit from our eBooks. Advance your career through our exclusive networking parties and life sciences job board.

    Cutting Edge


    Cutting Edge Information provides customized research and benchmarking reports to pharmaceutical, biotechnology and other life science companies. We provide off-the-shelf and customized research for key areas including medical affairs, clinical development, market access, regulatory affairs, marketing management, sales and HCP fair market value.



    Biosave.com brings together the best Life Science promotions, product releases, featured products, publications, videos and events from 100’s of leading Life Science suppliers. Updated 24 hours a day, Biosave is constantly uploading special promotions and exciting product news that you won’t find anywhere else. Our goal is to provide our users with the most exclusive product information to help reach that all important purchasing decision.



    Gate2Biotech is a portal that unites biotechnological community in Central Europe. It covers all the news in the field of biotechnology. Thanks to the the portal the companies engaged in the field can easily search for research institutions and other partners to solve technical problems they are facing and here they can also present their services offer to potential partners from the Czech Republic and abroad. Gate2Biotech portal serves as a bridge connecting scientific and commercial sector. It incorporates offices and support organizations dedicated to promoting transfer of innovative technologies into a unified communication platform of Czech and international biotechnologies. As a mediator of information it draws attention to biotechnologies and support of their application and transfer into practice. It also functions as a tool for encouraging non-professionals (especially scientists and students) towards innovative business or applied research.

    International Journal of Medical Engineering and Informatics


    IJMEI promotes an understanding of the structural/functional aspects of disease mechanisms and the application of technology towards the treatment/management of such diseases. It seeks to promote interdisciplinary collaboration between those interested in the theoretical and clinical aspects of medicine and to foster the application of computers and mathematics to problems arising from medical sciences. IJMEI includes authoritative review papers, the reporting of original research, and evaluation reports of new/existing techniques and devices. Each issue also contains a comprehensive information service.

    Medical News Today


    Medical News Today is the largest independent medical and health news site on the web - with over 10,000,000 monthly unique users it is ranked number one for medical news on all major search engines. Medical News Today is used by pharmaceutical, biotech and health organizations, advertising agencies, PR companies and vertical ad networks to deliver targeted campaigns to HCPs, patients and caregivers. To find out how Medical News Today can help you to reach the right audience contact peter@medicalnewstoday.com or visit www.medicalnewstoday.com.



    Absave.com is the leading savings website for Antibodies and Immunological Products. Search our extensive database of Antibodies, Kits, Proteins & Peptides, Reagents, etc. to find the best savings!

    Drug Development Technology


    Drugdevelopment-technology.com covers every aspect of the drug development and research process, from conception to pre-FDA approval. Our global network of journalists updates the site with the latest and most significant industry developments. This coverage allows us to provide everyone - from senior management through to research and QA staff – with in-depth reviews of the latest projects, advance notice of new product releases and analysis of the latest procedural and legislative developments.



    PharmaVision offers a consultancy service providing independent pharmaceutical thematic research to the healthcare industry, the investment community and competitive intelligence specialists. We perform due diligence research and provide expert commentary in healthcare. Our reports combine scientific analysis in drug delivery, R&D technologies and pharmaceutical products including patient modelling, product/technology forecasts and market trends evaluation.

    Technology Networks


    Founded in 2000, Technology Networks is established as the leading news provider for life science and drug discovery professionals. In addition, we provide unique content including webcasts, videos, application notes and posters from recent conferences. Our portfolio now includes around 30 focussed scientific communities, all of which are accessible free of charge within TechnologyNetworks.com



    PMR (www.pmrcorporate.com) is a British-American company providing market information, advice and services to international businesses interested in Central and Eastern European countries as well as other emerging markets. PMR's key areas of operation include business publications (through PMR Publications), consultancy (through PMR Consulting) and market research (through PMR Research ). Being present on the market since 1995, offering high international standards in projects and publications, as well as providing one of the most frequently visited and top-ranked websites, PMR is one of the largest companies of its type in the region.

    International Pharmaceutical Industry


    IPI gives you an insight into all areas of Biopharm, Medical, Pharmaceutical and Healthcare. IPI provides a proven supportive means of communication to the Pharmaceutical, Bio Pharmaceutical, Nutraceutical and Medical Devices industry, incorporating the latest in research and technology innovations, regulatory guidelines, marketing and communication strategies.

    Bioportfolio Limited


    BioPortfolio.com is a leading news, information and knowledge resource covering the global life science industries impacted by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to source core information on specific bio-related topics, to collate relevant data associated with each topic and to point the user to relevant knowledge resources

    International Journal of Biotechnology


    IJBT provides an international forum and refereed authoritative source of information in the field of Biotechnology and Biotechnics, with emphasis on management and economics, as well as the political and social issues. It aims to disseminate knowledge, provide a learned reference in the field, and establish channels of communication between academic and research experts, policy makers and executives in industry, commerce and investment institutions.

    Lab Bulletin


    Lab Bulletin is a free online resource for scientists and laboratory professionals where you can catch up on the latest news for laboratory products and services. You will find an extensive directory of laboratory suppliers and manufacturers enabling you to contact companies quickly and easily to request further information. Lab Bulletin also publishes four free monthly E-Newsletters keeping you up-to-date with all of the latest laboratory products and industry news directly to your inbox. We have dedicated E-Newsletters for Chromatography and Spectroscopy, Microscopy and Image Analysis, weekly Industry News updates and our monthly Lab Bulletin E-Newsletter sent out to over 29,000 readers worldwide. To request your free copy click here

    International Journal of Bioinformatics Research and Applications


    Bioinformatics is an interdisciplinary research field that combines biology, computer science, mathematics and statistics into a broad-based field that will have profound impacts on all fields of biology. The emphasis of IJBRA is on basic bioinformatics research methods, tool development, performance evaluation and their applications in biology. IJBRA addresses the most innovative developments, research issues and solutions in bioinformatics and computational biology and their applications.

    Drug Discovery Today


    Drug Discovery Today covers the whole of the preclinical drug discovery process. The reviews are cutting edge, written by experts in their respective fields and cover all aspects of drug discovery from genomic and proteomic approaches, computational drug design, medicinal chemistry and the translation of these sciences to therapies.

    International Journal of Computational Biology and Drug Design


    IJCBDD, an International Society of Intelligent Biological Medicine official journal, bridges the gap between two very important, complementary disciplines, computational biology and drug design. Through advances in high-throughput genome sequencing and digital imaging technologies, biocomputing, drug design and medical research have unfolded new, predictive sciences such as genomics, proteomics, lipidomics, metabolomics, cytomics and pharmaconomics. These promote new computational, statistical and biomedical approaches to drug design/development, besides unleashing the potential of significantly more accurate, effective personalised diagnosis, therapeutics and patient care.



    Pharmalicensing (www.pharmalicensing.com) is the premier biopharmaceutical Open Innovation resource designed for professionals involved with partnering, licensing and business development worldwide. Actively supporting all forms of partnering and in- and out-licensing activities, Pharmalicensing utilizes the unique online Showcase Profiling & Discover services, as well as its renowned Partnering Search service leveraging its global network of industry experts, to enable companies to identify and engage with appropriate partners around the world. Pharmalicensing is actively utilized by many tens of thousands of industry professionals each month. Pharmalicensing is a division of Cognis Group, Inc.



    LabRoots is a free, social networking site that enables scientists, engineers, and other technical professionals to connect, collaborate with, and learn from each other. LabRoots fosters world-wide scientific communication and incorporates the newest social networking technologies. LabRoots allows scientists to connect with each other as they describe their research interests on a myriad of unique features and tools, discovering meaningful collaborations across geographic boundaries and fields of expertise.



    Established in October 2003, PharmiWeb Solutions is an energetic, innovative provider of web-based solutions for the pharmaceutical sector, with customers such as AstraZeneca, Roche, Servier Laboratories, and Merck With solutions in three key areas: Online Publishing, e-Business and Mobile Computing, we deliver connectivity – between people and applications – unlocking islands of data and knowledge. We own some of the sector’s most innovative Online Publications: PharmiWeb.com, HospitalPharma.com and Detail-Direct.com. We are actively developing solutions for Mobile Computing platforms. For example, our PharmiTabTM e-pharmacy solution runs real-time patient data and prescribing transactions in a busy hospital environment, on a TabletPC, wireless client/server platform. e-Business solutions range from e-Detailing, to Online Market Research, all designed to increase reach, increase sales, and to reduce administration and costs.



    Pharmalicensing (www.pharmalicensing.com) is the premier biopharmaceutical Open Innovation resource designed for professionals involved with partnering, licensing and business development worldwide. Actively supporting all forms of partnering and in- and out-licensing activities, Pharmalicensing utilizes the unique online Showcase Profiling & Discover services, as well as its renowned Partnering Search service leveraging its global network of industry experts, to enable companies to identify and engage with appropriate partners around the world. Pharmalicensing is actively utilized by many tens of thousands of industry professionals each month. Pharmalicensing is a division of Cognis Group, Inc.

    Select Science


    SelectScience is an independent, online information resource for the worldwide scientific community, and the home of trusted information for laboratory scientists. Discover impartial, expert opinion and trusted reviews about latest laboratory equipment and techniques; plus videos, application notes and science news from around the world. Become a member for free today.



    Labsave is the leading savings website for Laboratory Equipment and Lab Supplies. We work closely with the top suppliers in the world to bring you the best products at the most competitive prices. We are constantly striving to secure the biggest and most exclusive offers that you won’t find anywhere else! http://www.labsave.com/



    CanBiotech - A Portal and B2B Outsourcing Marketplace for the Biotech and Pharmaceutical Industry. The Marketplace features the Outsourcing Services Showcase; the Portal features our biopharmaceutical and venture capital directories and databases. Publications include the BioMedical Outsourcing Report and the Bio Outsourcing Asia© Publication.



    FarmavitaR+ is the professional network of experts and service providers. Network is gathering local consultants from 90 countries in Europe, Asia, North America, Latin America, Australia and Africa. Management of international, multi-centre projects is our core competence. FarmavitaR+ is providing solutions related to pharmaceutical, medical device, food supplement and cosmetic products. Scope of services is related to solutions for product development, quality assurance, clinical trials, product registration, portfolio analysis, lifecycle management, vigilance/risk management, pricing/reimbursing, market access and promotional compliance. FarmavitaR+ is brand name of Farmavita Regulanet Ltd. Visit https://farmavitar.com for more information. Outsource anything you can think of!

    Marriott Regents Park

    128 King Henry's Road
    London NW3 3ST
    United Kingdom

    Marriott Regents Park

    This 4 star north London hotel in zone 2 is the perfect destination for the astute business traveler as well as the leisure guest that knows how convenient north London hotels are, as a base from which to explore the city .Bond Street is just 3 stops from Swiss Cottage underground station on the Jubilee Line, so you can be shopping, exploring the sights and taking in one of London’s world-renowned West End shows in less than 15 minutes when you stay at this hotel near central London. At the same time, the hive of activity that is Camden Town, the chic shops, cafes and restaurants of Primrose Hill and ZSL’s London Zoo in Regents Park are all just a short walk from this hotel in north London.



    speaker image






    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.


    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.


    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SMI Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.


    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@smi-online.co.uk

    Event Title


    Read More

    I would like to speak at an event

    I would like to attend an event

    I would like to sponsor/exhibit at an event


    Sign up
    Forgotten Password?

    Contact SMi GROUP LTD

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SMi Group Ltd, 1 Westminster Bridge Road, London, SE1 7XW, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smi-online.co.uk Email: events@smi-online.co.uk
    Registered in England No: 3779287 VAT No: GB 976 2951 71

    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.

    Thank you for visiting our event

    If you would like to receive further information about our events, please fill out the information below.

    By ticking above you are consenting to receive information by email from SMi.
    Full details of our privacy policy can be found here https://www.smi-online.co.uk/privacy-legals/privacy-policy/.
    Should you wish to update your contact preferences at any time you can contact us at data@smi-online.co.uk.
    Should you wish to be removed from any future mailing lists please click on the following link http://www.smi-online.co.uk/opt-out